https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=27558626&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 275586262017081720191211
1466-503466112016NovInternational journal of systematic and evolutionary microbiologyInt J Syst Evol MicrobiolBorrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States.487848804878-488010.1099/ijsem.0.001445Lyme borreliosis (LB) is a multisystem disease caused by spirochetes in the Borrelia burgdorferisensu lato (Bbsl) genospecies complex. We previously described a novel Bbsl genospecies (type strain MN14-1420T) that causes LB among patients with exposures to ticks in the upper midwestern USA. Patients infected with the novel Bbsl genospecies demonstrated higher levels of spirochetemia and somewhat differing clinical symptoms as compared with those infected with other Bbsl genospecies. The organism was detected from human specimens using PCR, microscopy, serology and culture. The taxonomic status was determined using an eight-housekeeping-gene (uvrA, rplB, recG, pyrG, pepX, clpX, clpA and nifS) multi-locus sequence analysis (MLSA) and comparison of 16S rRNA gene, flaB, rrf-rrl, ospC and oppA2 nucleotide sequences. Using a system threshold of 98.3 % similarity for delineation of Bbsl genospecies by MLSA, we demonstrated that the novel species is a member of the Bbsl genospecies complex, most closely related to B. burgdorferisensu stricto (94.7-94.9 % similarity). This same species was identified in Ixodes scapularis ticks collected in Minnesota and Wisconsin. This novel species, Borrelia mayonii sp. nov, is formally described here. The type strain, MN14-1420, is available through the Deutsche Sammlung von Mikroorganismen und Zelkulturen GmbH (DSM 102811) and the American Type Culture Collection (ATCC BAA-2743).PrittBobbi SBSDepartment of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.Respicio-KingryLaurel BLBDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.SloanLynne MLMDepartment of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.SchrieferMartin EMEDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.ReplogleAdam JAJDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.BjorkJennaJMinnesota Department of Health, St. Paul, MN, USA.LiuGongpingGMinnesota Department of Health, St. Paul, MN, USA.KingryLuke CLCDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.MeadPaul SPSDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.NeitzelDavid FDFMinnesota Department of Health, St. Paul, MN, USA.SchiffmanElizabethEMinnesota Department of Health, St. Paul, MN, USA.Hoang JohnsonDiep KDKWisconsin Department of Health Services, Madison, WI, USA.DavisJeffrey PJPWisconsin Department of Health Services, Madison, WI, USA.PaskewitzSusan MSMUniversity of Wisconsin-Madison, Madison, WI, USA.BoxrudDavidDMinnesota Department of Health, St. Paul, MN, USA.DeedonAleciaAWisconsin Department of Health Services, Madison, WI, USA.LeeXiaXUniversity of Wisconsin-Madison, Madison, WI, USA.MillerTracy KTKNorth Dakota Department of Health, Bismarck, ND, USA.FeistMichelle AMANorth Dakota Department of Health, Bismarck, ND, USA.StewardChristopher RCRWisconsin Department of Health Services, Madison, WI, USA.TheelElitza SESDepartment of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.PatelRobinRDepartment of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.IrishCole LCLDepartment of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.PetersenJeannine MJMDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.engCC999999Intramural CDC HHSUnited StatesJournal Article20160824
EnglandInt J Syst Evol Microbiol1008996001466-50260DNA, Bacterial0RNA, Ribosomal, 16SIMAnimalsBacterial Typing TechniquesBorrelia burgdorferi Groupclassificationgeneticsisolation & purificationDNA, BacterialgeneticsFemaleGenes, BacterialHumansIxodesmicrobiologyLyme DiseaseMidwestern United StatesMinnesotaPhylogenyRNA, Ribosomal, 16SgeneticsSequence Analysis, DNAWisconsin
2016826602017818602016826602017111ppublish27558626NIHMS839007PMC521495710.1099/ijsem.0.001445Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005;18:484–509.PMC119597016020686Babady NE, Sloan LM, Vetter EA, Patel R, Binnicker MJ. Percent positive rate of Lyme real-time polymerase chain reaction in blood, cerebrospinal fluid, synovial fluid, and tissue. Diag Microbiol Infect Dis. 2008;62:464–466.18947959Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev. 1986;50:381–400.PMC3730793540570Bil-Lula I, Matuszek P, Pfeiffer T, Woźniak M. Lyme borreliosis-the utility of improved real-time PCR assay in the detection of Borrelia burgdorferi infections. Adv Clin Exp Med. 2015;24:663–670.26469112Dworkin MS, Schwan TG, Anderson DE, Borchardt SM. Tick-borne relapsing fever. Infect Dis Clin North Am. 2008;22:449–468. vii.PMC372582318755384Hinckley AF, Connally NP, Meek JI, Johnson BJ, Kemperman MM, Feldman KA, White JL, Mead PS. Lyme disease testing by large commercial laboratories in the United States. Clin Infect Dis. 2014;59:676–681.PMC464641324879782Johnson RC, Schmid GP, Hyde FW, Steigerwalt AG, Brenner DJ. Borrelia burgdorferi sp. nov.: etiologic agent of Lyme disease. Int J Syst Bacteriol. 1984;34:496–497.Lindgren E, Jaenson TGT. Lyme Borreliosis in Europe: Influences of Climate and Climate Change, Epidemiology, Ecology and Adaptation Measures. Copenhagen, Denmark: World Health Organization; 2006. [accessed 5/2/2016]. http://www.euro.who.int/__data/assets/pdf_file/0006/96819/E89522.pdf.Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman RB, DeMarco J, Iyer R, Cox ME, Holmgren D, Wormser GP. Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migrans. Eur J Clin Microbiol Infect Dis. 2012;31:791–795.21842448Margos G, Vollmer SA, Cornet M, Garnier M, Fingerle V, Wilske B, Bormane A, Vitorino L, Collares-Pereira M, et al. A new Borrelia species defined by multilocus sequence analysis of housekeeping genes. Appl Environ Microbiol. 2009;75:5410–5416.PMC272547919542332Margos G, Hojgaard A, Lane RS, Cornet M, Fingerle V, Rudenko N, Ogden N, Aanensen DM, Fish D, Piesman J. Multilocus sequence analysis of Borrelia bissettii strains from North America reveals a new Borrelia species, Borrelia kurtenbachii. Ticks Tick Borne Dis. 2010;1:151–158.PMC300069021157575Margos G, Wilske B, Sing A, Hizo-Teufel C, Cao W, Chu C, Scholz H, Straubinger RK, Fingerle V. Borrelia bavariensis sp. nov. is widely distributed in Europe and Asia. Int J Sys Evol Microbiol. 2013;63:4284–4288.23838444Pritt BS, Mead PS, Johnson DK, Neitzel DF, Respicio-Kingry LB, Davis JP, Schiffman E, Sloan LM, Schriefer ME, et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis. 2016;16:556–564.PMC497568326856777Schotthoefer AM, Frost HM. Ecology and Epidemiology of Lyme Borreliosis. Clin Lab Med. 2015;35:723–766.26593254Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461–473.21903253Steere AC. Lyme disease. N Engl J Med. 2001;345:115–125.11450660van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, Ramselaar AC, Kramer MD, Dankert J. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993;17:708–717.7903558Zückert WR. Laboratory maintenance of Borrelia burgdorferi. Curr Protoc Microbiol. 2007;Chapter 12(Unit 12C.1)18770608